Paradigm Capital analyst Scott McAuley shaved a bit off his target price for Spectral Medical in a Sunday report while retaining a Buy rating on the stock.
Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Spectral Medical (TSE:SDI – Get Rating) had its price target decreased by equities researchers at Stifel Nicolaus from C$0.65 to C$0.55 in a note issued to investors on Friday, BayStreet.CA reports. Spectral Medical Price Performance About Spectral Medical (Get Rating) Standard Diversified, Inc is a holding company, which owns and operates subsidiaries in a variety […]
50 Patients Randomized to Date out of the 150 Total Target to be Enrolled Reports Significant Uptick in Screening and Enrollment Activities TORONTO, Jan..
Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments - read this article along with other careers information, tips and advice on BioSpace